Cara Therapeutics files amended 8-K to correct investor presentation for proposed merger with Tvardi Therapeutics

Tvardi Therapeutics, Inc.

Merger agreement with Tvardi Therapeutics and merger sub was signed on December 17, 2024.
Asset Purchase Agreement with Vifor Fresenius Medical Care Renal Pharma for disposition of assets was signed on December 17, 2024.
Stockholder support agreements and lock-up agreements were filed with the SEC on December 17, 2024.
This amendment corrects formatting errors in the investor presentation originally filed on December 18, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.